药物对比
Semaglutide vs Tirzepatide
比较Semaglutide与Tirzepatide治疗2型糖尿病和减重。双重GIP/GLP-1受体激动剂与GLP-1受体激动剂：疗效、安全性、口服选择及主要差异。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes or obesity comparing leading incretin-based therapies to achieve potentially greater glycemic control and weight reduction.
结论
Tirzepatide may deliver superior glycemic and weight-loss outcomes for many, but Semaglutide offers an oral option and extensive data; neither is universally better.
全部药物对比